tiprankstipranks
Trending News
More News >
BioView Ltd. (IL:BIOV)
:BIOV
Israel Market

Bio View (BIOV) Income Statement

Compare
0 Followers

Bio View Income Statement

Last quarter (Q2 2024), Bio View's total revenue was 8.52M, a decrease of -2.43% from the same quarter last year. In Q2, Bio View's net income was 980.50K. See Bio View’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
25.66M 34.77M 29.14M 30.51M 25.96M
Gross Profit
15.56M 21.38M 16.67M 17.59M 15.78M
Operating Expenses
18.44M 20.61M 16.57M 14.04M 13.61M
Depreciation and Amortization
1.70M 1.82M 1.50M 1.48M 1.23M
EBITDA
-943.00K 2.93M 2.61M 4.03M 2.43M
Operating Income
-2.88M 766.00K 1.15M 2.95M 1.20M
Other Income/Expenses
19.00K 31.00K -276.00K -267.00K -60.00K
Pretax Income
-2.86M 797.00K 875.00K 2.68M 1.14M
Net Income
-3.15M 383.00K 587.00K 2.18M 884.00K
Per Share Metrics
Basic EPS
-0.02 0.00 0.05 0.16 0.06
Diluted EPS
-0.02 0.00 0.05 0.16 0.06
Weighted Average Shares Outstanding
140.07M 135.43M 13.91M 13.98M 14.06M
Weighted Average Shares Outstanding (Diluted)
138.64M 139.08M 13.91M 13.98M 14.06M
Currency in ILS

Bio View Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis